Overview
Status
Active
Registry date
2024-02-14
Share capital
100,000.00 PLN
Registered address
ul. Zakrzowska 19/203, 51-318 Wrocław, Poland
Email
Electronic delivery address
AE:PL-74996-75655-WDTUC-14
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Jarosław Sadłek – President of the Management Board
Wojciech Józef Sadłek – Attorney-in-fact
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jarosław Sadłekage 63 | 500 | $13,506.21 | 50% |
Wojciech Józef Sadłekage 59 | 500 | $13,506.21 | 50% |
Jarosław Sadłek and Wojciech Józef Sadłek hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The main business activity of GUY Laroche focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on February 14, 2024.
The headquarters is located at: ul. Zakrzowska 19, 51-318 Wrocław.
The management board consists of: Jarosław Sadłek (President of the Management Board).
The share capital of the company is PLN 100,000 (approx. $27,012).
Last updated: 2026-04-08